Clinical Trials Browser

OTHER_GOV × Carcinoma × Etoposide × Clear all

NCT05910177 2024-03-06

Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Camrelizumab Combined With Etoposide and Cisplatin

Phase 2 Recruiting

Carcinoma, Uterine Cervical Neoplasms